World Health Assembly 2017

Transparency for Innovation & Access to Medicines: What are the benefits & risks, obstacles & solutions?

During the week of the 70th World Health Assembly, this event in Geneva will bring together governments, industry, civil society and others to explore the potential of increasing transparency in the pharmaceutical sector and discuss the challenges and risks involved in the process.

Debates regarding increased transparency in the pharmaceutical sector have been gathering momentum at national and global levels and have also been central to the United Nations Secretary-General’s High-Level Panel on Access to Medicines report.

Specific areas for increased transparency will be discussed, such as medicine pricing, costs of R&D and manufacturing, and the patent status of medicines.

Speakers include: Catharina Boehme, CEO, FIND; Clemens-Martin Auer, Director-General, Austrian Federal Ministry of Health; Fumie Griego, Assistant Director-General, International Federation of Pharmaceutical Manufacturers & Associations; James Love, Director, Knowledge Ecology International; and Vasee Moorthy, Coordinator, Research, Ethics, Knowledge Uptake, Health Systems & Innovation Cluster, WHO. The event will be moderated by Suerie Moon, Research Director, Global Health Centre, the Graduate Institute.

Organized by the Global Health Centre at the Graduate Institute in collaboration with FIND

When? Tuesday, 23 May 2017 | 15.00 – 16.30

Maison de la paix, Petal 2, Auditorium

15.00-15.10 – Welcome and opening remarks

  • Ilona Kickbusch, Director, Global Health Centre, the Graduate Institute and FIND Board member

15.10-16.00 – Presentations

  • Catharina Boehme, CEO, FIND
  • Clemens-Martin Auer, Director General, Austrian Federal Ministry of Health
  • Fumie Griego, Assistant Director General, International Federation of Pharmaceutical Manufacturers & Associations
  • James Love, Director, Knowledge Ecology International
  • Vasee Moorthy, Coordinator Research, Ethics, Knowledge Uptake, Health Systems and Innovation Cluster, World Health Organization

Moderator: Suerie Moon, Research Director, Global Health Centre, the Graduate Institute

16.00-16.25 – Dialogue with the panel and the audience

16.25-16.30 – Closing remarks

  • Malebona Precious Matsoso, Director-General, Department of Health, South Africa

Panelists’ presentations will be followed by a moderated discussion with the audience.

Join us for this panel discussion. You are kindly requested to register your attendance online, free of charge.

For more information, please see the programme and the event website.